financetom
Business
financetom
/
Business
/
Sportradar Group Breaks Even in Q2, Revenue Rises; Raises Guidance; Shares Up 6.3% Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sportradar Group Breaks Even in Q2, Revenue Rises; Raises Guidance; Shares Up 6.3% Pre-Bell
Aug 13, 2024 5:11 AM

07:48 AM EDT, 08/13/2024 (MT Newswires) -- Sportradar Group ( SRAD ) reported a breakeven Q2 Tuesday, as it did during the same quarter a year earlier.

Analysts surveyed by Capital IQ expected earnings of 0.02 euros ($0.02) per share.

Revenue for the quarter ended June 30 was 278.4 million euros, compared with 216.4 million euros a year earlier. Analysts surveyed by Capital IQ expected 263.4 million euros.

The company raised its full-year 2024 revenue guidance to 1.07 billion euros from the previous guidance of 1.06 billion euros. Analysts surveyed by Capital IQ expect 1.06 billion.

Shares of Sportradar Group ( SRAD ) were up 6.3% in recent premarket activity.

Price: 12.00, Change: +0.71, Percent Change: +6.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Sanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R
Oct 17, 2024
Last week, Sanofi SA ( SNY )  said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. The deal could be valued at about 15 billion euros ($16.4 billion), making it one of the largest European transactions this year. Sanofi ( SNY ) is likely to retain a minority stake in the...
What's Going On With XPeng Stock Today?
What's Going On With XPeng Stock Today?
Oct 17, 2024
XPeng Inc. ( XPEV ) shares are trading lower on Tuesday. Shares of U.S.-listed Chinese stocks are trading lower after China’s September exports missed estimates. Concerns over the effectiveness of China’s latest stimulus measures have also rattled investors. According to Benzinga Pro, XPEV stock has lost over 25% in the past year. Investors can gain exposure to the stock via Invesco WilderHill Clean...
Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Rani Therapeutics Shares Fall After $10 Million Registered Direct Securities Offering Priced
Oct 17, 2024
01:40 PM EDT, 10/15/2024 (MT Newswires) -- Rani Therapeutics Holdings ( RANI ) shares fell 23% in recent Tuesday trading after the company priced a registered direct offering of securities for gross proceeds of about $10 million. The company agreed to sell 3 million shares of class A common stock, prefunded warrants for 333,333 shares and series C common warrants...
Medirom Healthcare Shares Rise After Investment, Partnership With Elematec
Medirom Healthcare Shares Rise After Investment, Partnership With Elematec
Oct 17, 2024
01:44 PM EDT, 10/15/2024 (MT Newswires) -- Medirom Healthcare Technologies' ( MRM ) shares jumped 27% in recent trading Tuesday after the company said Elematec, a Toyota Tsusho group member, agreed to make an investment in its unit Medirom Mother Labs. Elematec is participating in Medirom Mother Labs' series A round with pre-money valuation at 9 billion yen ($60 million),...
Copyright 2023-2026 - www.financetom.com All Rights Reserved